JP Morgan Healthcare Conference - Day 1 Analysis: China and Merck

While unable to attend the JP Morgan Healthcare Conference in person, we leveraged the Amenity Viewer platform to keep tabs on the company presentation transcripts, apply our text analytics on the sentiment, and look for meaningful comments on two key themes that we have been monitoring:

1. China macro

2. Merck margin pressures after our “Deception”analysis signaled risk on the Q3 earnings call

We will continue to monitor presentations over the next couple of days to draw more insights. 

Please note: This in no way represents investment advice. All transcript text provided by S&P Global Market Intelligence.

JP Morgan Healthcare Conference: China Bulls Intact, Merck Acknowledges Challenges

China commentary remains bullish, in contrast to macro headlines and Apple

We used the Query Insights feature to identify only the meaningful comments relating to China and tariffs, rather than having to parse through more than 100 results that would come through a simple Ctrl-F on a browser window.  

  • Varian Medical Systems:

"China, despite some of the saber rattling in the newspapers and trade issues, we continue to see very strong market in China."

  • Illumina:

"I would say Q4 largely played out as we expected. And from a demand standpoint in China, which I think is the more important indicator, we don’t see an impact tariff-wise. It’s really been more of accelerating some orders from Q4 into Q3 and Q2."

Merck downticks vs Q3, more openly discusses headwinds

In our December 20 post, we highlighted risk to Merck’s margin outlook through the lens of our Deceptive Language analysis.  At the JP Morgan Conference, we got a clearer look into headwinds validating that risk.  While conference presentations typically skew positive due to the softball nature of the Q&A, Merck led off with a cautionary note, resulting in an Amenity Score of the transcript of 27, down from 49 on its Q3 earnings call.

  • Merck:

"I think ’19 is a very exciting year.  We’ve got these growth drivers, including oncology. I think we need to acknowledge, though, at the same time there’s some challenges,okay.  I mean, obviously, pricing is a challenge not just for Merck but across the industry.  And again, it underscores why being an innovating company is so important.  We’re going to face more headwinds as it relates to ForEx."

"There will be challenges with respect to the more mature and the LOE part of our portfolio with SIMPONI in Europe, for example, having to deal with generic HUMIRA."

"Within the United States, JANUVIA facing additional problems with respect to the doughnut hole calculation."

Start a free trial of Amenity Viewer today to analyze earnings call transcriptions and enable you to spot outliers, identify critical insights, and understand key drivers.

Transcript text provided by S&P Global Market Intelligence.

Copyright ©2019. All rights reserved.

January 15, 2019

Assured Research: Using Natural Language Processing to Create an Insurance Dashboard

We integrated insurance industry earnings call transcript data to visually represent key sentiment.
January 15, 2019

Grocery Sector Earnings Analysis: The Cost of Survival as Amazon Leans Into Delivery

Amazon is going full bore at the Grocery sector and delivery will be the battlefield. For a sector always dealing with margin pressure how will competitors in this space fare? For answers we leverage the power of our text analytics to quickly perform analysis at scale with our Query Insights feature to extract earnings sentiment from the phrase "delivery growth."
January 15, 2019

Apple's Investor Letter Analysis: Answering 4 Key Questions for Apple, Tech and Other China Risk

We apply our text analytics model to analyze Apple's January 2nd investor letter to help address four specific questions that go beyond the headlines that everyone already knows. How bad was it? Does our "Deception" Analysis reveal anything? Where else to look for China fallout? How does Apple's release compare to comments in the smartphone ecosystem? Find out in our article.
January 15, 2019

2018 Q4 Earnings Sentiment: Recapping Our Top Insights

While everyone is providing 2019 outlooks and forward-looking takes we review our top 4 insights from Q4 2018 based on our readership. Using our text analytics modeling we uncovered some interesting insights that would've been extremely difficult for professionals to determine with traditional analysis. What did our readers uncover? Read on to find out.

Stay Informed: Join Our Newsletter

Keep up to date with our analyses and how we're making changes.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
We respect your privacy. We will use your email to keep you informed about Amenity Analytics.